Work

Abstract A029: Biomarker analysis of patients with METΔex14 mutated non-small-cell lung cancer (NSCLC) treated with capmatinib in the GEOMETRY mono-1 study

Year: 2019

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-19-a029

Authors: Rebecca S. Heist, Edward B. Garon, Daniel S.W. Tan, Harry J.M. Groen, Takashi Seto, Egbert F. Smit, Lauren Fairchild, Alejandro Balbin, Ming Yan, Monica Giovannini, Mikhail Akimov, Banu Sankaran, Ngozi Nwana, Juergen Wolf

Institutions: Massachusetts General Hospital, University of California, Los Angeles, National Cancer Centre Singapore, University Medical Center Groningen, University of Groningen, National Hospital Organization Kyushu Cancer Center, The Netherlands Cancer Institute, Novartis (United States), Novartis (Switzerland), University Hospital Cologne

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2992624746

Cites:

Cited by: 3

Related to: 10